Bone‐Targeted Engineered Exosomes Delivering Betaine Alleviate Osteoporosis via Autophagy‐Driven Osteogenesis
Advanced Materials · 2026-11 · 38 (63)
DOI: 10.1002/adma.75185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 27.09.2026. Verfasst von Xiaorong Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen Universit…. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis, Autophagy, Exosomes. Die Arbeit nennt 81 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Scientific Research Start-up Funds of the Seventh Affiliated Hospital of Sun Yat-sen University.
Abstract (Originalsprache)
Dysregulated bone remodeling, attenuated endogenous osteogenic capacity, and the lack of bone‐targeting capability in therapeutics constitute the core challenges in current clinical interventions for osteoporosis. In this study, a hybrid nanodelivery system integrating betaine‐loaded metal‐organic frameworks with engineered exosomes (BZ@Exos) is constructed to restore bone metabolic homeostasis and improve bone microstructure. The engineered exosomes co‐overexpressing CXCR4 and CD47 proteins on the surface exhibit high bone tissue targeting efficiency and evade clearance by the mononuclear phagocyte system, while ZIF‐8 enables stable encapsulation of betaine. Internalized betaine promotes nuclear translocation of TFEB via targeted binding to the 14‐3‐3 protein, enhances autophagic flux in senescent bone marrow mesenchymal stem cells (BMSCs), and thereby facilitates their osteogenic differentiation. In parallel, BZ@Exos significantly inhibits osteoclast‐mediated bone resorption and restores bone metabolic homeostasis. In vivo assays demonstrate that intravenously administered BZ@Exos successfully reverses bone loss and alleviates senescence‐related phenotypes in ovariectomized rat models of osteoporosis. This novel therapeutic system with integrated functions of bone homeostasis remodeling, regenerative potential restoration, and precise targeting provides a new perspective for osteoporosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
- School of Materials Science and Engineering, Sun Yat-sen University, Guangzhou, Guangdong, China.
- School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China.
- School of Medicine, Sun Yat-sen University, Shenzhen, Guangdong, China.
ORCID-Profile: Leli Zeng, Yihang Pan, Chao Zhang, Yunhui Si
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Scientific Research Start-up Funds of the Seventh Affiliated Hospital of Sun Yat-sen University
Zitieren
APA
Li, X., Li, M., Li, Z., Gu, J., Mo, L., Zhu, Y., Chen, Y., Zeng, L., Pan, Y., Zhang, C., & Si, Y. (2026). Bone‐Targeted Engineered Exosomes Delivering Betaine Alleviate Osteoporosis via Autophagy‐Driven Osteogenesis. Advanced Materials, 38(63). https://doi.org/10.1002/adma.75185
Vancouver
Li X, Li M, Li Z, Gu J, Mo L, Zhu Y, et al. Bone‐Targeted Engineered Exosomes Delivering Betaine Alleviate Osteoporosis via Autophagy‐Driven Osteogenesis. Advanced Materials. 2026;38(63). doi:10.1002/adma.75185
BibTeX
@article{Li2026,
author = {Li, Xiaorong and Li, Mengsha and Li, Zhenghao and Gu, Jiaying and Mo, Linzhen and Zhu, Yuetong and Chen, Yang and Zeng, Leli and Pan, Yihang and Zhang, Chao and Si, Yunhui},
title = {Bone‐Targeted Engineered Exosomes Delivering Betaine Alleviate Osteoporosis via Autophagy‐Driven Osteogenesis},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {63},
doi = {10.1002/adma.75185}
}
EUVIMED